Astrazeneca Pharma India Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 75.00% of Astrazeneca Pharma India, FIIs hold 2.64%, DIIs hold 7.09% and the public holds 15.27%. Promoter holding was unchanged from Jun 2026.

Get an alert when Astrazeneca Pharma India reports results or its shareholding changes. Free account.

Promoters

75.00%

unchanged QoQ

FIIs

2.64%

−0.04 pp QoQ

DIIs

7.09%

+1.01 pp QoQ

Public

15.27%

−0.97 pp QoQ

Astrazeneca Pharma India shareholding, quarter by quarter

QuarterPromotersFIIsDIIsPublicShareholders
Sep 202675.00%2.64%7.09%15.27%30,408
Jun 202675.00%2.68%6.08%16.24%29,338
Mar 202675.00%2.78%5.79%16.42%29,007
Dec 202575.00%2.71%5.55%16.73%31,551
Sep 202575.00%2.74%5.26%17.00%32,914
Jun 202575.00%3.03%4.55%17.41%34,378
Mar 202575.00%2.89%4.65%17.45%32,466
Dec 202475.00%2.92%5.21%16.85%27,322
Sep 202475.00%2.90%5.08%17.02%27,615
Jun 202475.00%2.79%4.99%17.21%27,169
Mar 202475.00%2.73%3.77%18.50%29,418
Dec 202375.00%2.66%2.76%19.57%29,032

Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹15.04k cr, the promoter group's 75.00% stake is worth ₹11.28k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Astrazeneca Pharma India shareholding: common questions

What is the promoter holding in Astrazeneca Pharma India?

Promoters hold 75.00% of Astrazeneca Pharma India as of Sep 2026. Their stake was unchanged from Jun 2026.

How much do FIIs hold in Astrazeneca Pharma India?

Foreign institutional investors (FIIs) held 2.64% of Astrazeneca Pharma India in Sep 2026, −0.04 pp versus Jun 2026.

How much do mutual funds and other DIIs hold in Astrazeneca Pharma India?

Domestic institutional investors (DIIs), which include mutual funds and insurers, held 7.09% of Astrazeneca Pharma India in Sep 2026, +1.01 pp versus Jun 2026.

Is the promoter holding in Astrazeneca Pharma India pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Astrazeneca Pharma India.

How has Astrazeneca Pharma India's promoter holding changed in the last year?

Promoter holding moved from 75.00% in Sep 2025 to 75.00% in Sep 2026 (unchanged).

How many shareholders does Astrazeneca Pharma India have?

Astrazeneca Pharma India had 30,408 shareholders in Sep 2026, compared with 29,338 in Jun 2026.